Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Toronto
$105,000.00
Determining "acceptable uncertainty:" A case study of uncertain diagnosis in cystic fibrosis newborn screening
FY 2009-10
Summary
Newborn screening (NBS) is used to identify infants with treatable disorders so that they may benefit from early detection and treatment. Cystic fibrosis (CF), determined by genetic testing, is often part of NBS programs because early diagnosis can improve health. But, some infants with a positive result for CF may not get the disease. The effect of this uncertainty on families of infants with uncertain results can be overwhelming and could lead to confusion about the health of their child. Since uncertainty may be unavoidable with the introduction of new genetic tests, can a level of acceptable uncertainty be determined?
Acceptable uncertainty would be examined, for example, by determining models, levels, or types of uncertainty. Uncertainty models could then be examined in parents of infants with uncertain positive CF results through interviews focusing on the family's response to and interpretation of uncertainty. Some models or levels of uncertainty may be considered more acceptable than others due to the seriousness of the consequences of the test, the novelty of the genetic tests, or other reasons. For example, some parents may accept that a new test will give uncertain results but may need extra care if the uncertainty leads to difficult choices. From this research, the project will help doctors make decisions about when new genetic tests should be introduced into the health care system, how to talk to parents about uncertain test results, how to tailor discussions about uncertainty to individuals, and how to measure and quantify uncertainty, among other issues.
The increased use of genetic testing for a greater number of diseases will lead to an increase in uncertain test results. Uncertainty will become more common in health care in the future. Because of this, it is important to learn how to properly manage uncertainty in order to improve health care delivery at the individual and population level.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
206172
Name
Marshall Jennifer A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Health systems / services
Prcname2
Doctoral Research Awards - B
Projecttitle
Determining "acceptable uncertainty:" A case study of uncertain diagnosis in cystic fibrosis newborn screening
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Bioethics; Communication Of Uncertainty; Genetic Testing; Health Services Research; Healthcare Ethics; Newborn Screening; Population Health; Risk Communication; Uncertain Diagnosis; Uncertainty Measures
Abstract
Newborn screening (NBS) is used to identify infants with treatable disorders so that they may benefit from early detection and treatment. Cystic fibrosis (CF), determined by genetic testing, is often part of NBS programs because early diagnosis can improve health. But, some infants with a positive result for CF may not get the disease. The effect of this uncertainty on families of infants with uncertain results can be overwhelming and could lead to confusion about the health of their child. Since uncertainty may be unavoidable with the introduction of new genetic tests, can a level of acceptable uncertainty be determined?
Acceptable uncertainty would be examined, for example, by determining models, levels, or types of uncertainty. Uncertainty models could then be examined in parents of infants with uncertain positive CF results through interviews focusing on the family's response to and interpretation of uncertainty. Some models or levels of uncertainty may be considered more acceptable than others due to the seriousness of the consequences of the test, the novelty of the genetic tests, or other reasons. For example, some parents may accept that a new test will give uncertain results but may need extra care if the uncertainty leads to difficult choices. From this research, the project will help doctors make decisions about when new genetic tests should be introduced into the health care system, how to talk to parents about uncertain test results, how to tailor discussions about uncertainty to individuals, and how to measure and quantify uncertainty, among other issues.
The increased use of genetic testing for a greater number of diseases will lead to an increase in uncertain test results. Uncertainty will become more common in health care in the future. Because of this, it is important to learn how to properly manage uncertainty in order to improve health care delivery at the individual and population level.
Competitiondate
200910
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Marshall, Jennifer A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~